Cargando…
Inactivation of DNA repair—prospects for boosting cancer immune surveillance
The emergence of drug resistance depends on the ability of the genome of cancer cells to constantly mutate and evolve under selective pressures. The generation of new mutations is accelerated when genes involved in DNA repair pathways are altered. Notably, although the emergence of new mutations fos...
Autores principales: | Truini, Anna, Germano, Giovanni, Bardelli, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260742/ https://www.ncbi.nlm.nih.gov/pubmed/30486892 http://dx.doi.org/10.1186/s13073-018-0603-9 |
Ejemplares similares
-
Boosting immunity after CoronaVac
por: Sester, Martina, et al.
Publicado: (2022) -
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance
por: Amodio, Vito, et al.
Publicado: (2023) -
Clinical trials of mTOR inhibitors to boost immunity to viral infection in older adults
por: Dzankic, Paula Juricic, et al.
Publicado: (2021) -
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
por: Amodio, Vito, et al.
Publicado: (2021) -
African fictions to boost the scientific culture in Africa
por: Kenmoe, Stephane
Publicado: (2022)